Approvals/TGA/OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection

Approved

STANDARD

OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection

Maxx Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2ca7cb4c44f71e7f
Product Name: OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection
Artg Id: 288223
Artg Name: OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection
Sponsor: Maxx Pharma Pty Ltd
Company Detail Path: /organization/maxx-pharma-pty-ltd
Artg Date: 2018-12-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a1811238de9d0e28753eaed58556131e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c6fe51b9645d0783b9b704e1b2d1a0fe.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2ca7cb4c44f71e7f

Type

Standard